DCGO - DocGo: The Gravy Train Ends

2024-06-21 12:22:40 ET

Summary

• Today, we take a more in-depth look at DocGo Inc., a hybrid healthcare company that will be going through a transitional period in 2025.
• Recent results show strong growth in revenues and earnings, but the company will lose a large revenue stream next year.
• However, DocGo should remain profitable through this transition, and core revenues will show impressive growth.
• The stock has seen some insider buying recently, and the company is repurchasing some of its own equity as well.
• An analysis of DocGo follows in the paragraphs below.

Today, we take a look at an interesting hybrid company in the healthcare space called DocGo Inc. ( DCGO ). Approximately 25% of the company's overall revenues come from medical transportation services. The rest is garnered from its mobile health services offerings. The company has benefited greatly from the unprecedented immigration across the U.S. southern border over the past few years (more on that later). Its various product set is provided in 30 states and the United Kingdom....

For further details see: